San Carlos, CA, United States of America

Gregory D Plowman

This inventor holds 44 USPTO granted patents and 14 published patent applications, plus 2 CIPO patents and 4 EPO patents, primarily in Biopharmaceutical Innovations. Top assignees: Sugen Incorporated, Exelixis, Inc., Genentech, Inc.. Active years: 1992-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gregory D Plowman. Retrieved from https://idiyas.com/inventor/gregory-d-plowman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 44 (Patent Applications = 14)

% Patents Active = 65.9

CIPO Patents = 2 (Patent Applications = 15)

EPO Patents = 4 (Patent Applications = 10)

Average Co-Inventor Count = 2.9

ph-index = 12

Forward Citations = 549(Granted Patents)

Location History:

Seattle, WA (US) (1992 - 1999)
San Carlos, CA (US) (1998 - 2016)
New York, NY (US) (2015 - 2021)

Company Filing History:

Bristol-Myers Squibb Compnay

Eli Lilly and Company

10. 1 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 1992-2021

Loading Chart...

Areas of Expertise:

Checkpoint Inhibitor

Bispecific Antibodies

Fibroblast Growth Factor Receptor-3

p53 Pathway Modifiers

Anti-alpha5/beta1 Antibodies

Diagnosis and Treatment

Polynucleotides

Human PAK5 Protein Kinase

Transcript Imaging

Proliferative Disorders

Epithelins

Heparin-binding Epithelial Growth

44 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11203640 - Checkpoint inhibitor bispecific antibodies (2021-12-21),

2. 9375488 - Compounds to fibroblast growth factor receptor-3 (FGFR3) and methods of treatment (2016-06-28),

3. 9284376 - Antibodies (2016-03-15),

4. 8962275 - Anti-α5β1 antibodies and uses thereof (2015-02-24),

5. 8840887 - Antibodies (2014-09-23),

6. 8771942 - SCDs as modifiers of the p53 pathway and methods of use (2014-07-08),

7. 8350010 - Anti-alpha5/beta1 antibody (2013-01-08),

8. 8268548 - MAP3Ks as modifiers of the p53 pathway and methods of use (2012-09-18),

9. 8153384 - Marks as modifiers of the p53 pathway and methods of use (2012-04-10),

10. 8124740 - Anti- α5 β1 antibodies and uses thereof (2012-02-28),

11. 8105785 - Mylks as modifiers of branching morphogenesis and methods of use (2012-01-31),

12. 7993829 - HPRP4s modifiers of the p53 pathway and methods of use (2011-08-09),

13. 7973138 - Antibodies (2011-07-05),

14. 7119174 - Diagnosis and treatment of AUR1 and/or AUR2 related disorders (2006-10-10),

15. 7115710 - Diagnosis and treatment of PTP related disorders (2006-10-03),

Title: Gregory D Plowman: Pioneering Inventor from San Carlos

Introduction: Gregory D Plowman is a renowned inventor hailing from San Carlos, California. His innovative spirit and dedication to pushing the boundaries of technology have led to groundbreaking inventions in various fields.

Latest Patents: Gregory D Plowman holds several patents in the areas of renewable energy, artificial intelligence, and medical devices. His most recent patents focus on sustainable energy solutions and cutting-edge healthcare technologies.

Career Highlights: With a career spanning over two decades, Gregory D Plowman has worked for leading tech companies, research institutions, and universities. He has been instrumental in developing disruptive technologies that have revolutionized the way we live and work.

Collaborations: Throughout his career, Gregory D Plowman has collaborated with top engineers, scientists, and researchers to bring his inventions to life. His collaborative efforts have resulted in successful products and solutions that have had a significant impact on society.

Conclusion: Gregory D Plowman's passion for innovation and his relentless pursuit of excellence have established him as a trailblazer in the world of technology. His contributions to various industries continue to inspire the next generation of inventors and innovators.

Profile summary based on public USPTO records.